Eqis Capital Management, Inc. Collegium Pharmaceutical, Inc Transaction History
Eqis Capital Management, Inc.
- $1.19 Billion
- Q1 2024
A detailed history of Eqis Capital Management, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 5,515 shares of COLL stock, worth $177,472. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,515Holding current value
$177,472% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
231Shares Held
39.5MCall Options Held
104KPut Options Held
15.4K-
Black Rock Inc. New York, NY5.87MShares$189 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$84.8 Million1.65% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$83.2 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.33MShares$75 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.83MShares$59 Million2.43% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...